ProQR Therapeutics N.V (PRQR) Invested Capital: 2021-2024
Historic Invested Capital for ProQR Therapeutics N.V (PRQR) over the last 1 years, with Dec 2024 value amounting to $108.1 million.
- ProQR Therapeutics N.V's Invested Capital rose 76.84% to $108.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $108.1 million, marking a year-over-year increase of 76.84%. This contributed to the annual value of $108.1 million for FY2024, which is 75.90% up from last year.
- ProQR Therapeutics N.V's Invested Capital amounted to $108.1 million in Q4 2024, which was up 76.84% from $61.1 million recorded in Q4 2023.
- Over the past 5 years, ProQR Therapeutics N.V's Invested Capital peaked at $175.8 million during Q4 2021, and registered a low of $61.1 million during Q4 2023.
- For the 3-year period, ProQR Therapeutics N.V's Invested Capital averaged around $84.2 million, with its median value being $83.8 million (2022).
- As far as peak fluctuations go, ProQR Therapeutics N.V's Invested Capital slumped by 52.47% in 2022, and later spiked by 76.84% in 2024.
- Quarterly analysis of 4 years shows ProQR Therapeutics N.V's Invested Capital stood at $175.8 million in 2021, then crashed by 52.47% to $83.5 million in 2022, then dropped by 26.80% to $61.1 million in 2023, then soared by 76.84% to $108.1 million in 2024.
- Its Invested Capital stands at $108.1 million for Q4 2024, versus $61.1 million for Q4 2023 and $83.5 million for Q4 2022.